German Pharma Stock News

In late October 2025, MEAG, acting for Munich Re, joined Meritage Group LP and Ullico Infrastructure Fund as equity investors in TowerPoint Infrastructure Partners LLC, a leading private owner of US wireless infrastructure assets. This investment highlights Munich Re's move to diversify its assets and tap into the rising demand for digital infrastructure in the United States. Next, we'll explore how Munich Re's entry into US wireless infrastructure could strengthen its diversification...

Drägerwerk KGaA (XTRA:DRW3) posted current net profit margins of 3.5%, edging out last year’s 3.4% as earnings grew 6.6% over the past year. Looking ahead, annual earnings are forecast to rise 9.3% with revenues set to increase 3.6% yearly. However, these rates trail broader German market expectations. Investors are weighing ongoing margin improvements and a valuation that sits well below both industry and peer averages, all amid questions about the sustainability of recent gains. This comes...

Redcare Pharmacy (XTRA:RDC) just released its earnings for the first nine months of 2025, showing sales growth to €2,145.71 million and a narrowed net loss of €8.71 million compared to last year. See our latest analysis for Redcare Pharmacy. Redcare Pharmacy’s latest earnings update arrives as the share price continues to face headwinds, sliding nearly 46% year-to-date. While the recent results point to real progress on revenue growth and loss reduction, the market remains cautious. With a...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...

Scout24 (XTRA:G24) reported a revenue growth forecast of 10.2% per year, surpassing the broader German market's projected 6% expansion. Over the past five years, the company’s earnings have increased at an average annual rate of 17.1%, though this slowed to just 3% in the most recent year. Net profit margins narrowed to 28.1% from last year’s 30.6%, providing investors with a balanced view of sustained growth, along with some margin compression to monitor moving forward. See our full analysis...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

With a median price-to-sales (or "P/S") ratio of close to 0.6x in the Luxury industry in Germany, you could be forgiven...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Key Insights Significant insider control over PFISTERER Holding implies vested interests in company growth 52% of the...

Knorr-Bremse (XTRA:KBX) is guiding for robust earnings growth of 15.55% per year, while revenue is forecast to increase 5.4% annually. Yet, the company’s net profit margin stands at 5.3%, down from 7.4% last year, reflecting a trend of earnings contraction with a 2.8% yearly decline over the past five years. Shares are currently trading at €80.7, well below the estimated fair value of €111.65, and the price-to-earnings ratio of 30.8x is lower than direct peers but higher than the wider German...

BASF (XTRA:BAS) has returned to profitability, with net profit margins improving compared to last year. Over the past five years, however, the company’s earnings have declined by an average of 16.6% per year. Looking ahead, BASF’s earnings are forecast to grow at 19.4% annually, exceeding the German market’s average of 16.7%. However, anticipated revenue growth of 2.4% lags behind the expected 6.1% rate for the broader German market. Investors face a mixed picture as they weigh signs of...

Nokia recently announced a multi-year partnership with E.ON SE to upgrade the utility's mission-critical telecommunications network infrastructure across Germany, targeting improved automation, flexibility, and energy savings. The project positions E.ON’s grid, which already connects 1.4 million renewable energy plants, as a benchmark for secure, energy-efficient digital infrastructure supporting Europe’s energy transition. We’ll explore how E.ON’s collaboration with Nokia to cut network...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

HWA AG ( ETR:H9W ) shares have had a horrible month, losing 26% after a relatively good period beforehand. The drop...

DATA MODUL Aktiengesellschaft Produktion und Vertrieb von elektronischen Systemen ( ETR:DAM ) shareholders have had...

It's not a stretch to say that Dermapharm Holding SE's ( ETR:DMP ) price-to-earnings (or "P/E") ratio of 17x right now...

AUTO1 Group SE's ( ETR:AG1 ) price-to-sales (or "P/S") ratio of 0.9x may not look like an appealing investment...

Earlier this week, Kepler Cheuvreux downgraded Vossloh AG from Buy to Hold, citing valuation concerns following a strong rally and highlighting potential delays in infrastructure projects by Deutsche Bahn, Vossloh’s key customer. This move has drawn attention to how reliant Vossloh is on timely execution of its main customer’s investment plans, elevating focus on the near-term business outlook. We’ll explore how the analyst’s concerns about delays in Deutsche Bahn’s infrastructure projects...

Zalando (XTRA:ZAL) just named Anna Dimitrova as its new Chief Financial Officer. The company is bringing in a seasoned finance leader as it sharpens its focus on growth and its evolving e-commerce strategy. See our latest analysis for Zalando. Zalando’s shares have faced a challenging run in 2024, with a 1-year total shareholder return of -10.8% and a 5-year total return of -71.9%. This reflects ongoing pressure across the sector despite recent leadership changes. While the latest executive...

HelloFresh (XTRA:HFG) extended its loss-making streak this year, with net losses compounding at an alarming 70.3% annual rate over the past five years and no reported improvement in profitability. Despite these persistent losses and a modest 1.8% revenue growth forecast—well behind the German market’s 6% pace—the company is expected to turn profitable within three years. Forecasted earnings growth is 87.98% per year, a rate well above average. Shares are trading at €7.12, a sharp discount to...

Covestro (XTRA:1COV) remains in the red, with losses deepening at an annualized rate of 53% over the past five years. Despite that backdrop, the company’s outlook remains compelling for investors: revenue is expected to grow 3.5% per year, while earnings are forecast to bounce back at a rapid 98.16% per year. This positions Covestro on track for profitability within three years. Shares are currently trading at €59.84, below an estimated fair value of €68.78 and lower than peer and sector...

Deutsche Lufthansa (XTRA:LHA) posted an annual earnings growth rate of 68.1% over the past five years, with its net profit margin rising to 4.6% from 3.3% a year earlier. While forward-looking forecasts call for earnings to climb by 3.85% per year and revenue to rise 3.7% annually, both metrics lag behind broader German market expectations. Still, the combination of improved profitability and a Price-to-Earnings ratio of 5.1x, well below industry peers and the global airline average, makes...

Symrise (XTRA:SY1) shared its third quarter 2025 sales results, reporting organic growth of 1.4% despite tough year-on-year comparisons and the impacts of portfolio changes and currency fluctuations. Investors are watching how sustained project activity influences outlook. See our latest analysis for Symrise. Symrise shares are down 28.3% year-to-date, while the total shareholder return over the past year has dipped 32.8%. The latest positive sales update and a strong project pipeline have...

MilliporeSigma, the North American Life Science business of Merck KGaA, recently announced a partnership with Promega Corporation to co-develop advanced technologies for drug screening and discovery, integrating expertise in organoids, synthetic chemistry, and cellular assays. This collaboration aims to provide innovative workflows for real-time tracking of cellular activity and studying protein interactions in 3D cell cultures, reinforcing Merck KGaA's role in life sciences...